150 related articles for article (PubMed ID: 9226215)
1. Hodgkin's disease treated with neck radiation is associated with increased antibody-dependent cellular cytotoxicity against human extraocular muscle cells.
Ringel MD; Taylor T; Barsouk A; Wall JR; Freter CE; Howard RS; Diehl L; Burman KD
Thyroid; 1997 Jun; 7(3):425-32. PubMed ID: 9226215
[TBL] [Abstract][Full Text] [Related]
2. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
3. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
[TBL] [Abstract][Full Text] [Related]
4. Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL; Cox RS; McDougall IR
N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
[TBL] [Abstract][Full Text] [Related]
5. New assays for the measurement of serum antibodies reactive with eye muscle membrane antigens confirm their significance in thyroid-associated ophthalmopathy.
Barsouk A; Wengrowicz S; Scalise D; Stolarski C; Nebes V; Sato M; Wall JR
Thyroid; 1995 Jun; 5(3):195-200. PubMed ID: 7580267
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy--roles of class II MHC antigen expression and gamma-interferon action of effector and target cells.
Hiromatsu Y; Fukazawa H; How J; Wall JR
Clin Exp Immunol; 1987 Dec; 70(3):593-603. PubMed ID: 3124997
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
9. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy.
Hiromatsu Y; Fukazawa H; Guinard F; Salvi M; How J; Wall JR
J Clin Endocrinol Metab; 1988 Sep; 67(3):565-70. PubMed ID: 3410941
[TBL] [Abstract][Full Text] [Related]
10. Immunologically mediated cytotoxicity against human eye muscle and thyroid cells in euthyroid and thyrotoxic Graves' ophthalmopathy.
Medeiros-Neto G; Zhang ZG; Lima N; Iacona A; Liberman A; Salvi M; Wall JR
Autoimmunity; 1991; 9(4):293-300. PubMed ID: 1954309
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
12. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies.
Rodien P; Madec AM; Ruf J; Rajas F; Bornet H; Carayon P; Orgiazzi J
J Clin Endocrinol Metab; 1996 Jul; 81(7):2595-600. PubMed ID: 8675583
[TBL] [Abstract][Full Text] [Related]
14. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.
Gupta S; Fernandes G
Clin Exp Immunol; 1981 Jul; 45(1):205-14. PubMed ID: 6975681
[TBL] [Abstract][Full Text] [Related]
16. Thyroid abnormalities associated with treatment of malignant lymphoma.
Tamura K; Shimaoka K; Friedman M
Cancer; 1981 Jun; 47(11):2704-11. PubMed ID: 7260863
[TBL] [Abstract][Full Text] [Related]
17. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunological abnormalities.
Salvi M; Zhang ZG; Haegert D; Woo M; Liberman A; Cadarso L; Wall JR
J Clin Endocrinol Metab; 1990 Jan; 70(1):89-94. PubMed ID: 2294141
[TBL] [Abstract][Full Text] [Related]
18. Failure to detect complement-mediated antibody-dependent cytotoxicity against human orbital tissue cells in the serum of patients with thyroid-associated ophthalmopathy.
Dillon J; Zhang ZG; Hiromatsu N; Bernard M; Salvi M; Wall JR
Autoimmunity; 1989; 5(1-2):125-32. PubMed ID: 2519012
[TBL] [Abstract][Full Text] [Related]
19. [Monocyte cytotoxicity in Hodgkin's disease].
Pehamberger H; Ludwig H; Pötzi P; Pietschmann H; Knapp W
Acta Med Austriaca; 1979; 6(5):249-51. PubMed ID: 555222
[TBL] [Abstract][Full Text] [Related]
20. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
